close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,082.37 +4.62 (+0.43%)
Streaming Delayed Price Updated: 12:48 PM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 702,310
Open 1,077.95
Bid (Size) 1,082.13 (40)
Ask (Size) 1,082.60 (40)
Prev. Close 1,077.75
Today's Range 1,074.38 - 1,084.51
52wk Range 623.78 - 1,111.99
Shares Outstanding 956,580,893
Dividend Yield 0.55%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The Great Pivot: Navigating the Rollercoaster 2025 Market as the Final Bell Approaches
As the sun sets on December 29, 2025, the U.S. stock market stands at a historic crossroads, capping off a year defined by extreme volatility, political brinkmanship, and a definitive shift in monetary... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
S&P 500 Tests Resilience: Technical Pullback Follows Historic Record Highs as 2025 Draws to a Close
The S&P 500 (NYSE:SPY) entered the final week of 2025 in uncharted territory, having notched a series of historic closing records that culminated in a Christmas Eve milestone. However, as the calendar... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks

Performance

YTD
+39.1%
+39.1%
1 Month
+0.6%
+0.6%
3 Month
+49.0%
+49.0%
6 Month
+39.6%
+39.6%
1 Year
+39.9%
+39.9%

More News

Read More
News headline image
The Trillion-Dollar Apothecary: Inside Eli Lilly’s Era of Metabolic Dominance
Via PredictStreet
Topics Earnings Economy Intellectual Property
News headline image
This Beaten-Down Stock Just Jumped By 8%. Time to Buy? ↗
Via The Motley Fool
News headline image
Eli Lilly & Co (NYSE:LLY) Stands Out as a Secure Dividend Growth Stock ↗
Via Chartmill
News headline image
Novo Nordisk Slashes Weight Loss Drug Price By Up To 50% In China: Report ↗
Via Stocktwits
Topics Intellectual Property
News headline image
The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA. ↗
Via The Motley Fool
News headline image
Reflecting On Pharmaceuticals Stocks’ Q3 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ)
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
3 Drug Stocks to Buy at a Discount ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
The Best Stocks to Invest $50,000 in Right Now ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Here Are My Top 3 Growth Stocks to Buy Now ↗
Via The Motley Fool
News headline image
Should You Invest in Ozempic Maker Novo Nordisk in 2026? ↗
Via The Motley Fool
News headline image
Eli Lilly’s New Drug Data Sets Up a High-Stakes 2026 ↗
Via MarketBeat
News headline image
The Ghost Town Effect: How Thin Holiday Liquidity is Jolting US Equities
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Sector Rotation: 2 Smart Money Moves for 2026 ↗
Via MarketBeat
News headline image
This Smallcap Pharma Stock Is Gaining Retail Buzz Ahead Of A Key FDA Ruling ↗
Via Stocktwits
News headline image
Buying This Pharmaceutical Stock Could Make You a Millionaire Retiree ↗
Via The Motley Fool
News headline image
The Biological Turing Point: How AlphaFold 3 and the Nobel Prize Redefined the Future of Medicine
Via TokenRing AI
Topics Artificial Intelligence Initial Public Offering
News headline image
The Great Broadening: How AI Implementation Reshaped the Non-Tech Bottom Line in 2025
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
News headline image
Is Eli Lilly Pulling Ahead in the Weight Loss Drug Battle? ↗
Via The Motley Fool
News headline image
Pfizer’s 2026 Outlook Misses the Mark as Post-Pandemic Hangover and Patent Cliff Loom
Via MarketMinute
Topics Economy Intellectual Property
News headline image
The Oral Revolution: Novo Nordisk’s High-Stakes Bet on the Wegovy Pill
Via PredictStreet
Topics Economy Intellectual Property World Trade
News headline image
The Vaccine Vanguard: Inside Sanofi’s $2.2 Billion Strategic Bet on Dynavax
Via PredictStreet
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Trillion-Dollar Pharma: A Deep Dive into Eli Lilly’s (LLY) Dominance in the Weight-Loss Era
Via PredictStreet
Topics Economy Government Intellectual Property
News headline image
As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?
Via Barchart.com
Topics Workforce

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 1,082.37
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 12/29/25 12:48 PM ET
What is the market capitalization of Eli Lilly?
The market capitalization of Eli Lilly is 1,035.37B
How many shares of Eli Lilly are outstanding?
Eli Lilly has 1,035B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today